Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Intangibles (2019 - 2025)

Historic Intangibles for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to $300000.0.

  • Silence Therapeutics' Intangibles fell 1050.64% to $300000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $300000.0, marking a year-over-year decrease of 1050.64%. This contributed to the annual value of $312000.0 for FY2024, which is 1381.22% down from last year.
  • Silence Therapeutics' Intangibles amounted to $300000.0 in Q3 2025, which was down 1050.64% from $317000.0 recorded in Q2 2025.
  • Over the past 5 years, Silence Therapeutics' Intangibles peaked at $377911.7 during Q2 2023, and registered a low of $4135.8 during Q3 2021.
  • In the last 5 years, Silence Therapeutics' Intangibles had a median value of $314500.0 in 2024 and averaged $243544.3.
  • Per our database at Business Quant, Silence Therapeutics' Intangibles crashed by 7185.85% in 2021 and then soared by 147455.84% in 2023.
  • Quarter analysis of 5 years shows Silence Therapeutics' Intangibles stood at $175241.4 in 2021, then skyrocketed by 114.18% to $375337.0 in 2022, then fell by 6.09% to $352487.1 in 2023, then dropped by 11.49% to $312000.0 in 2024, then fell by 3.85% to $300000.0 in 2025.
  • Its Intangibles was $300000.0 in Q3 2025, compared to $317000.0 in Q2 2025 and $310000.0 in Q1 2025.